Notice of Intent to Sole Source.pdf

Synopsis No. 75N94025Q00200

NICHD, Office of Acquisitions

Title: Complete Genomics DNBseq T1+

Presolicitation

SYNOPSIS

General Information

Document Type: Presolicitation

Synopsis Number: 75N94025Q00200

Posted Date: August 25, 2025

Original Response Date: September 4, 2025

Current Response Date: September 4, 2025

Set Aside: N/A

NAICS Code: 334516

Contracting Office Address

NICHD

6710B Rockledge Dr.

Bethesda, Maryland 20892

Description

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS

TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL

OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH), National Institute of Child Health and Human

Development (NICHD), Office of Acquisitions (OA) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:

Complete Genomics LLC

2904 Orchard Parkway

San Jose CA, 95134

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 334516 with a Size Standard 1,000.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the

Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($250,000).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR)

Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using

FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-

Competition Requirements.

GENERAL INFORMATION

1. Title: Complete Genomics DNBseq T1+

2. Background Information: The NIEHS Epigenomics core proposes the procurement of an

Complete Genomics DNBseq T1+ sequencer. The DNBseq T1+ is a highly efficient mid-throughput sequencer with Q40 accuracy at low cost. Its optimized performance and flexible sequencing options enable scientists to seamlessly explore genomics. It will greatly increase sequencing capacity and reduce sequencing cost in the Epigenomics core to meet the increasing research demands from NIEHS investigators. It is also the only sequencing platform that supports the new Stereo-seq spatial transcriptomics method that provides the highest spatial resolution to study biology, disease, and human health.

DNBSEQ-T1+, powered by DNBSEQ™ technology, is a highly efficient mid-throughput sequencer with Q40 accuracy, delivering 25Gb – 1.2Tb of data in under 24 hours. Its optimized performance and flexible sequencing options enable scientists to seamlessly explore genomics—from discovery to validation and production-scale sequencing—while maintaining cost-effectiveness. It will greatly increase sequencing capacity and reduce sequencing cost in the Epigenomics core to meet the increasing research demands from NIEHS investigators. It is also the only sequencing platform that supports the new Stereo-seq spatial transcriptomics method that provides the highest spatial resolution to study biology, disease, and human health.

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the

Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management

(SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by September 4, 2025 at 9:00 AM Eastern time and must reference solicitation number 75N94025Q00200. Responses may be submitted electronically to http://www.sam.gov/

Mr. Michael Falzone, Contracting Officer at Michael.falzone@nih.gov. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”